Multidisciplinary neoadjuvant management for potentially curable pancreatic cancer

E-ISSN： 2045-7634|4|8|1224-1239

ISSN： 2045-7634

Source： Cancer Medicine, Vol.4, Iss.8, 2015-08, pp. : 1224-1239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant Therapy in Pancreatic Cancer

By Quiros Roderick M. Brown Kimberly M. Hoffman John P.

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 267-273

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic cancer — Neoadjuvant therapy

By Krempien R. Munter M. Harms W. Debus J.

The Chinese-German Journal of Clinical Oncology, Vol. 6, Iss. 2, 2007-04 ,pp. : 162-169

Springer Publishing Company

Access to resources Recommend Favorite

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

By Katz Matthew

Annals of Surgical Oncology, Vol. 17, Iss. 7, 2010-07 ,pp. : 1794-1801

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

By Irmscher Sabrina

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 2059-2060

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

By Palmer Daniel

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 2061-2061

Springer Publishing Company

Access to resources Recommend Favorite